Continuing their long-standing partnership, Eli Lilly has again retained The Chase Group to recruit a physician/scientist for a crucial clinical development role. This position will serve as the medical lead and subject matter expert for their priority oncology development program in prostate cancer.
This Senior Medical Advisor will focus initially on the product development of their CDK 4/6, Abemaciclib. We seek a Board Certified Medical Oncologist who will bring clinical research experience as Principal Investigator or Co-PI and therapeutic area expertise, including standards of care, current medical options for diagnosis and treatment of relevant conditions based upon franchise and pipeline products.
For consideration, please contact Moira Newbanks at 913-663-3100 or email@example.com.